BioCryst Pharmaceuticals, Inc. · 2 weeks ago
Intern, Corporate Communications (Durham, NC)
BioCryst Pharmaceuticals, Inc. is a fast-growing biotech company dedicated to improving the lives of people with rare diseases. As a Corporate Communications Intern, you will support the Corporate Communications Team by engaging in various activities such as internal and external communications and event planning.
BiotechnologyClinical TrialsTherapeutics
Responsibilities
Develop content (e.g., news articles, department pages, program updates, etc.) for our global intranet platform and support development of biweekly employee newsletter
Oversee company-wide mass email coordination calendar
Partner with other departments and individuals across diverse locations to ensure the global employee perspective is properly reflected in internal communications
Maintain and organize internal platforms, including photo and video library
Support weekly traditional monitoring efforts to track and share company and relevant industry news
Build and maintain trackers (e.g., media touchpoint tracker)
Conduct ad hoc research to inform various communications activities
Support coordination of all-employee meetings and ad hoc internal events, including pre-meeting set-up and post-meeting communications. Contribute to agenda development, slide creation and speaker prep
Bring a keen eye to the department’s communications by proofreading documents and editing content for audience and platform
Qualification
Required
Working towards a bachelor's degree in Communications or related discipline with a minimum 3.0 GPA
Exceptional written and verbal communicator
Self-starter who can work independently
Ability to be flexible and adjust quickly as priorities change
Team player who is willing to flex outside the prescribed role
Passionate about communications
Proficient in Microsoft Office Suite
Resume
Submit at least three samples of your work. These may include writing or video projects from a previous internship or coursework. Examples include: Press release, News article, Communications plan, Website copy, Social media post, Video script or edited video, Media monitoring report, References (2-3)
Company
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.76BKey Investors
MidCap FinancialNational Institute of Allergy and Infectious Diseases
2023-04-17Post Ipo Debt· $450M
2021-11-22Post Ipo Equity· $350M
2020-12-07Post Ipo Debt· $325M
Recent News
Company data provided by crunchbase